DJIA 16,515.13 -127.88 -0.77%
NASDAQ 4,783.46 -44.87 -0.93%
S&P 500 1,971.40 -17.47 -0.88%
market minute promo

Celgene (NASDAQ: CELG)

119.46 -4.58 (-3.69%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $119.29 -3.83%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $122.85
Previous Close $124.04
Daily Range $119.39 - $123.60
52-Week Range $83.16 - $140.72
Market Cap $94.4B
P/E Ratio 46.98
Dividend (Yield) $0.00 (0.0%)
Volume 3,597,876
Average Daily Volume 4,912,659
Current FY EPS $4.22




Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary

Manic Markets: Healthcare Bargains Worth Buying

Industry Focus is sifting through the healthcare rubble to find your gems.

CELG, PFE, REGN, RCPT Jim Cramer's Views

The Future Is ... OK; What You Can Trust, and What You Can't: Jim Cramer's Best Blogs

Jim Cramer’s 7 Lessons From the Stock Market’s Monumental Week

VUG, V, ORCL, CELG: ETF Inflow Alert

M&A Daily: Hedge Fund Hotels

Finally Oil Leads To A Rally - Cramer's Mad Money (8/27/15)

Kyle Bass's Latest IPR Missile Ventures Into Biologics And Threatens Amgen's $5B Enbrel Drug

Comments On The Market Correction; Focus On Biotechs: Large Caps

10 Reasons Why It's So Easy to Fall in Love With Celgene

A handy list of 10 reasons why Celgene may be at the head of the class in a very crowded biotech sector.

See More CELG News...

CELG's Top Competitors

CELG $119.46 (-3.69%)
Current stock: CELG
AMGN $153.07 (-1.81%)
Current stock: AMGN
GILD $105.95 (-1.70%)
Current stock: GILD
$0.00 (0.00%)
Current stock: